Literature DB >> 16628279

[Cardiac morphology and performance alterations and analysis of determinant factors of left ventricular hypertrophy in 40 patients with acromegaly].

Alessandra Ferri Casini1, Paula Bruna Araújo, Rosita Fontes, Sérgio Salles Xavier, Mônica R Gadelha.   

Abstract

Acromegaly has a high mortality rate due mainly to cardiovascular complications. The aim was to evaluate the determinant factors of left ventricular hypertrophy (LVH) and cardiac alterations in 40 acromegalic patients submitted to clinical-laboratorial studies and echocardiogram. The variables analyzed were age, sex, disease duration, arterial hypertension (AH), impaired glucose tolerance/DM, previous treatment with octreotide, GH and %IGF-I. Univaried analysis showed that patients with LVH were older (p= 0.031), had higher prevalence of AH (p= 0.009) and higher %IGF-I (p= 0.002), than those without LVH. Multivaried analysis showed AH and %IGF-I as determinants of LVH (p= 0.035 and p= 0.016). After dichotomizing of %IGF-I, a score was created and the frequency of LVH was 9%, 65%, 92% x 0, 1, 2; p< 0.0001. Prevalence of aortic ectasia was higher and valvar disease was smaller than reported in the literature. We conclude that AH and %IGF-I were determinants of LVH.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16628279     DOI: 10.1590/s0004-27302006000100012

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  5 in total

1.  Low frequency of cardniac arrhythmias and lack of structural heart disease in medically-naïve acromegaly patients: a prospective study at baseline and after 1 year of somatostatin analogs treatment.

Authors:  Leila Warszawski; Leandro Kasuki; Rodrigo Sá; Cintia Marques Dos Santos Silva; Isabela Volschan; Ilan Gottlieb; Roberto Coury Pedrosa; Mônica R Gadelha
Journal:  Pituitary       Date:  2016-12       Impact factor: 4.107

2.  Two-dimensional speckle tracking echocardiography demonstrates no effect of active acromegaly on left ventricular strain.

Authors:  I C M Volschan; L Kasuki; C M S Silva; M L Alcantara; R M Saraiva; S S Xavier; M R Gadelha
Journal:  Pituitary       Date:  2017-06       Impact factor: 4.107

3.  Low risk of coronary artery disease in patients with acromegaly.

Authors:  Cintia Marques Dos Santos Silva; G A B Lima; I C M Volschan; I Gottlieb; L Kasuki; L Vieira Neto; M R Gadelha
Journal:  Endocrine       Date:  2015-05-17       Impact factor: 3.633

Review 4.  Advances in Research on the Cardiovascular Complications of Acromegaly.

Authors:  Han Yang; Huiwen Tan; He Huang; Jianwei Li
Journal:  Front Oncol       Date:  2021-04-02       Impact factor: 6.244

5.  Pulmonary function testing and chest tomography in patients with acromegaly.

Authors:  Gustavo Bittencourt Camilo; Fernando Silva Guimarães; Débora Pedroza Guedes Silva; Roberto Mogami; Leandro Kasuki; Mônica Roberto Gadelha; Pedro Lopes Melo; Agnaldo José Lopes
Journal:  Multidiscip Respir Med       Date:  2013-11-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.